News

General newsMedia releases

MESSAGE FROM CHAIR AND CHIEF EXECUTIVE

August 2, 2018
Chief Executive Dale Fisher has announced that she will be leaving Peter MacCallum Cancer Centre to take on a national leadership role as CEO of Silver Chain, a leading home health and aged care provider.
Read more
Professor Michael MacManus
ResearchClinical research & trials

Better disease control with combination therapy in patients with early-stage follicular lymphoma

July 31, 2018
An international clinical trial - led by Peter Mac’s Professor Michael MacManus - has shown that a combination therapy significantly improves long-term disease control for patients with localised, follicular lymphoma compared to radiotherapy alone. Follicular lymphoma is the most common type of low-grade lymphoma and it is a slow progressing disease, making clinical trials difficult to conduct.
Read more
(Left to right) Dr Gabrielle Haeusler, Dr Marliese Alexander, Peter Mac Chief Executive Dale Fisher, Dr Elizabeth Pearson
General newsMedia releasesResearchClinical research & trials

Peter Mac researchers awarded Victorian Cancer Agency grants

July 12, 2018
Four Peter Mac researchers have been named as Victorian Cancer Agency (VCA) Fellowship grant recipients.
Read more
Featured servicesGeneral newsMedia releasesPatient & carer storiesClinical research & trials

SABR is feasible, safe and could delay lifelong hormone therapy for some men with advanced prostate cancer 

June 29, 2018
A Peter Mac clinical trial using a highly advanced, single-dose radiotherapy treatment has halted the spread of prostate cancer in some men, delaying the need for conventional lifelong hormone therapy.
Read more
General newsClinical research & trials

Peter Mac researchers win image of the year

June 27, 2018
A compilation of scans of eight Peter Mac patients, created by Professor Michael Hofman and his research team, has been declared “Image of the Year” by the Society of Nuclear Medicine and Molecular Imaging.
Read more
Professor Sherene Loi, head of the Translational Breast Cancer Genomics Laboratory at Peter Mac
General newsMedia releasesResearchClinical research & trials

New understanding of how the immune system responds to breast cancer

June 26, 2018
Peter Mac scientists have described in unprecedented detail how the immune system responds to breast cancer, identifying a potential new target for immunotherapy treatments.
Read more
General news

Collingwood wins the 2018 Peter Mac Cup

June 25, 2018
Collingwood has taken out the 26th Peter Mac Cup, beating Carlton by 20 points at the MCG on Sunday (11-13-79 to 9-5-59).
Read more
General news

Falling into a daydream: new art in Peter Mac’s youth ward

June 22, 2018
The walls of Peter Mac’s youth day ward and inpatient rooms have been transformed into a magical, whimsical world by acclaimed Australian artist Ghostpatrol.
Read more
Featured servicesGeneral news

Giving more patients access to information in their own language

June 22, 2018
The Australian Cancer Survivorship Centre - A Richard Pratt legacy (ACSC) at Peter Mac has launched a raft of new language resources for cancer survivors who don’t speak English as a first language.
Read more
General newsResearchClinical research & trials

Los Angeles to Peter Mac: scientist Jess Beach's story

June 18, 2018
Post-doctoral researcher Jess Beach, who specialises in ovarian cancer, moved across the globe to work with Peter Mac’s Professor David Bowtell. She has just started her first clinical trial in ovarian cancer: Targeting the C1 Subtype of High Grade Serous Ovarian Cancer (BEACON).
Read more